10Elms LLP’s DexCom DXCM Stock Holding History

10Elms LLP’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15K	Hold	32	–	–	﹤0.01%	513
2026 Q1	$2.01K	Buy	+32	New	+$2.23K	﹤0.01%	470

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

10Elms LLP's DXCM Position: Q2 2026 in Review

10Elms LLP held its DexCom (DXCM) position steady in Q2 2026 at 32 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

10Elms LLP first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

10Elms LLP held 32 shares of DexCom worth $2.15K as of Q2 2026.
10Elms LLP left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of 10Elms LLP's portfolio in Q2 2026, its #513 holding.
10Elms LLP first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.